BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24200798)

  • 1. Inhibition of postprandial hyperglycemia by either an insulin-dependent or -independent drug reduces the expression of genes related to inflammation in peripheral leukocytes of OLETF rats.
    Imai C; Harazaki T; Inoue S; Mochizuki K; Goda T
    Biosci Biotechnol Biochem; 2013; 77(11):2305-8. PubMed ID: 24200798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with DPP-4I Anagliptin or α-GI Miglitol Reduces IGT Development and the Expression of CVD Risk Factors in OLETF Rats.
    Imai C; Harazaki T; Inoue S; Mochizuki K; Goda T
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(4):313-21. PubMed ID: 26440638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.
    Mochizuki K; Fukaya N; Tanaka Y; Fuchigami M; Goda T
    Metabolism; 2011 Nov; 60(11):1560-5. PubMed ID: 21550076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1beta and tumour necrosis factor-alpha gene expression in rat peripheral leucocytes induced by intermittent sucrose loading.
    Tanaka Y; Mochizuki K; Fukaya N; Shimada M; Goda T
    Br J Nutr; 2009 Jul; 102(2):221-5. PubMed ID: 19138443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.
    Fukaya N; Mochizuki K; Tanaka Y; Kumazawa T; Jiuxin Z; Fuchigami M; Goda T
    Eur J Pharmacol; 2009 Dec; 624(1-3):51-7. PubMed ID: 19818342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of β2 integrin genes in rat peripheral leukocytes by inhibiting postprandial hyperglycemia.
    Mochizuki K; Shimada M; Tanaka Y; Fukaya N; Goda T
    Biosci Biotechnol Biochem; 2010; 74(12):2470-4. PubMed ID: 21150098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes.
    Fukaya N; Mochizuki K; Shimada M; Goda T
    Nutrition; 2009 Jun; 25(6):657-67. PubMed ID: 19216056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.
    Osonoi T; Saito M; Mochizuki K; Fukaya N; Muramatsu T; Inoue S; Fuchigami M; Goda T
    Metabolism; 2010 Dec; 59(12):1816-22. PubMed ID: 20667563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
    Fukuda-Tsuru S; Anabuki J; Abe Y; Yoshida K; Ishii S
    Eur J Pharmacol; 2012 Dec; 696(1-3):194-202. PubMed ID: 23022337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats.
    Fujita Y; Kojima H; Hidaka H; Fujimiya M; Kashiwagi A; Kikkawa R
    Diabetologia; 1998 Dec; 41(12):1459-66. PubMed ID: 9867213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
    Park SY; Choi YH; Lee W
    J Ethnopharmacol; 2008 Feb; 115(3):473-82. PubMed ID: 18068920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
    Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK
    Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models.
    Kong WH; Oh SH; Ahn YR; Kim KW; Kim JH; Seo SW
    J Agric Food Chem; 2008 Apr; 56(8):2613-9. PubMed ID: 18363357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100 Genes are Highly Expressed in Peripheral Leukocytes of Type 2 Diabetes Mellitus Patients Treated with Dietary Therapy.
    Kondo S; Mochizuki K; Hariya N; Saito M; Doguchi S; Osonoi T
    Drugs R D; 2021 Mar; 21(1):91-101. PubMed ID: 33464544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.
    Satoh-Asahara N; Sasaki Y; Wada H; Tochiya M; Iguchi A; Nakagawachi R; Odori S; Kono S; Hasegawa K; Shimatsu A
    Metabolism; 2013 Mar; 62(3):347-51. PubMed ID: 23062489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
    Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E372-9. PubMed ID: 21139073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
    Ishibashi K; Hara A; Fujitani Y; Uchida T; Komiya K; Tamaki M; Abe H; Ogihara T; Kanazawa A; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2013 Nov; 440(4):570-5. PubMed ID: 24103756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in α-glucosidase activities along the jejunal-ileal axis of normal rats by the α-glucosidase inhibitor miglitol.
    Mochizuki K; Hanai E; Suruga K; Kuranuki S; Goda T
    Metabolism; 2010 Oct; 59(10):1442-7. PubMed ID: 20153003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats.
    Lee HJ; Lee YH; Park SK; Kang ES; Kim HJ; Lee YC; Choi CS; Park SE; Ahn CW; Cha BS; Lee KW; Kim KS; Lim SK; Lee HC
    Metabolism; 2009 Aug; 58(8):1170-7. PubMed ID: 19477471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.